Frontlight ResearchEarly access
Trial site
Opća bolnica Karlovac
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes7 trials
- Obesity3 trials
- COPD1 trial
- Crohn's disease1 trial
- Heart failure1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 310 trials
- Phase 22 trials
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Novo Nordisk A/S8 trials
- Arrowhead Pharmaceuticals2 trials
- Chiesi Farmaceutici S.p.A.1 trial
- Shire1 trial
Running trials
Not yet recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
Withdrawn
Completed
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026